multiple sclerosis

Questcor Rises After Strong Shipping Numbers: Los Angeles Mover
Bloomberg
Sat, 09/8/12 - 10:41 am
Questcor
Acthar
multiple sclerosis
Sanofi signals Lemtrada confidence with CVR buyback
Reuters
Tue, 09/4/12 - 05:25 pm
CVRs
Sanofi
Lemtrada
MS
multiple sclerosis
Questor Shares Jump On Lower Medicaid Rebates Ahead
Investors.com
Tue, 09/4/12 - 11:50 am
rebates
Medicaid
Questor
Acthar
MS
multiple sclerosis
Teva $1 Billion Market Depends On New Test Of Laquinimod
Bloomberg
Mon, 08/27/12 - 10:33 am
Teva Pharmaceuticals
laquinimod
MS
multiple sclerosis
Acorda Therapeutics announced results of dalfampridine-ER study
Yahoo/Fly on the Wall
Mon, 08/13/12 - 12:01 pm
Acorda
dalfampridine-ER
MS
multiple sclerosis
Biogen, Bayer Drugs Don’t Slow MS Progress, Study Finds
Bloomberg
Tue, 07/17/12 - 05:53 pm
BiogenIdec
Bayer
MS
multiple sclerosis
beta interferon
Teva/Active Biotech MS pill accepted for review in Europe
Pharma Times, UK
Tue, 07/17/12 - 11:43 am
Teva Pharmaceuticals
Active Biotech
MS
multiple sclerosis
Europe
Questcor's Acthar Is One Hot Drug
Seeking Alpha
Fri, 07/13/12 - 01:28 pm
Acthar
Questcor
MS
multiple sclerosis
The Race To Cure Multiple Sclerosis
Seeking Alpha
Thu, 07/5/12 - 01:12 pm
MS
multiple sclerosis
Biogen Idec
Elan
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Bayer
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
Teva Pharmaceuticals
patents
Mylan
Momenta
Natco
Acorda Therapeutics
Copaxone
MS
multiple sclerosis
Teva says MS drug met goals in clinical trial
PharmPro
Sat, 06/16/12 - 02:09 pm
Teva Pharmaceuticals
Copaxone
multiple sclerosis
Teva announces results from GALA Phase III trial in MS
The Fly on the Wall
Thu, 06/14/12 - 08:19 am
Teva Pharmaceuticals
MS
multiple sclerosis
glatiramer acetate
Genzyme seeks approvals for MS drug
Boston Globe, MA
Wed, 06/13/12 - 12:55 pm
MS
multiple sclerosis
Genzyme
Sanofi
Lemtrada
Positive Data for Sanofi's Aubagio
Yahoo/Zacks.com
Mon, 06/4/12 - 10:56 am
Sanofi
Aubagio
Genzyme
multiple sclerosis
Your Warning Label Is My Sales Brochure
Motley Fool
Thu, 05/17/12 - 10:20 am
warnings
MS
Gilenya
multiple sclerosis
Novartis
Biogen Idec
Bayer
Teva Pharmaceuticals
Elan
Pfizer
New Caution Urged Over Sole Oral MS Drug On the Market
WSJ Online
Tue, 05/15/12 - 10:30 am
MS
multiple sclerosis
Novartis
Gilenya
FDA
Standard Review for Biogen's BG-12
Yahoo/Zacks
Sat, 05/12/12 - 11:51 am
Biogen Idec
BG-12
multiple sclerosis
Biogen Says Data Highlight Safety Profile For BG-12 MS Drug
FOX Business
Tue, 04/24/12 - 10:27 am
Biogen Idec
BG-12
multiple sclerosis
MS
Novartis limits use of Copaxone rival Gilenya
Globes, Israel
Sun, 04/22/12 - 01:31 pm
Novartis
Teva Pharmaceuticals
Gilenya
Copaxone
multiple sclerosis
New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec’s Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases
Yahoo/BusinessWire
Sat, 04/21/12 - 11:49 am
Biogen
Tysabri
Fampyra
BG-12
multiple sclerosis
amyotrophic lateral sclerosis
DAC HYP

Pages